This article is more than 5 years old. Information may no longer be current.

Aesculap acquires assets of Aragon Surgical Inc.

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Aesculap Inc. announced has acquired the assets of Aragon Surgical Inc., which specializes in advanced radiofrequency electrosurgical instruments for tissue fusion and cutting. According to a company press release, Aragon’s Caiman instruments are the only radiofrequency devices on the market with an articulating jaw.

“We are very excited about the inclusion of the Caiman product line into the Aesculap family of surgical instruments. The Caiman’s unique articulating jaw design and proprietary Lektrafuse technology provide improved clinical benefits. This acquisition will widen the scope of our surgical instrument portfolio and enhance Aesculap’s line of products to improve patient care,” Chuck DiNardo, president of Aesculap, stated in the release.